Home  »  Ipo Review  »  Infinium Pharmachem Ipo

Let’s have a detailed review of the company and analytics of the Infinium Pharmachem IPO release date, IPO offer price, subscription, Infinium Pharmachem Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 10
Price Band Rs 135
Listing At NSE, SME
Min. Order Quantity 1000 Shares
Listing Date Apr 17, 2023
Offer for Sale Rs Lakh
Fresh Issue Rs 2,526 Lakh
IPO Size Rs 2,526 Lakh
Tick Size 1

Infinium Pharmachem IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Live Performance – Infinium Pharmachem Share Price

Infinium Pharmachem IPO – Summary

Infinium Pharmachem IPOTheir Company was originally incorporated as Private Limited, under the Companies Act, 1956 (“Companies Act”) in the name and style of “M/s Infinium Pharmachem Private Limited” on November 21st, 2003 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Ahmedabad, Gujarat.

Later on, the company was converted into a public limited company, the name of the Company was changed to “Infinium Pharmachem Limited” and a fresh Certificate of Incorporation dated August 12th, 2022 was issued by the Registrar of Companies, Ahmedabad, Gujarat.


Infinium Pharmachem IPO Date

The opening and closing dates of Infinium Pharmachem IPO are Mar 31, 2023, and Apr 5, 2023, respectively.

Infinium Pharmachem IPO Subscription

Day / Date NII RII Total Subscription
1st Day – 31st Mar 0.06x 0.10x 0.08x
2nd Day –  3rd Apr 0.31x 0.57x 0.44x
3rd Day – 5th Apr 1.80x 1.86x 1.84x
Shares Offered or Net Issue 870,000 870,000 1,740,000

The shares subscribed by the public will be updated here.

Infinium Pharmachem IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Infinium Pharmachem Limited IPO Listing Date

Find the dates below on basis of allotment, refund, listing, and more:

Basis of Allotment Finalization Apr 11, 2023
Refunds Initiation Apr 12, 2023
Credit of Shares to Demat Account Apr 13, 2023
Share Listing Date Apr 17, 2023

Infinium Pharmachem IPO Price Band

The face value of each share is Rs.10, but the price band of the IPO is Rs.135 

Infinium Pharmachem IPO Equity Size

This Initial Public Issue of 1,875,000 Equity Shares of Rs.10 each for cash at a price of Rs.135 per equity share aggregating to Rs.2,526 Lakh.

Infinium Pharmachem IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 1,875,000 Equity Shares of Rs.10/ each.

Issue Size: 1,875,000 Equity Shares of Rs.10 each, aggregating to Rs.2,526 Lakh

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Infinium Pharmachem IPO – Live Performance

    The listing date of this IPO is Apr 17, 2023. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Infinium Pharmachem Share Price

    Infinium Pharmachem IPO Grey Market Premium

    The Infinium Pharmachem Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is Rs X. 

    Infinium Pharmachem IPO – Company Overview

    Their Promoters Sanjaykumar Viththalbhai Patel, Pravin Bhadabhai Madhani and others laid down the foundation of their company in the year 2003 as a Private Limited in the name of “M/s Infinium Pharmachem Private Limited” with a vision to establish itself as a globally integrated & admired Pharmaceutical & Healthcare Company.

    Later on, they converted Private Limited into a Public Limited Company in the name and style of “M/s Infinium Pharmachem Limited (Infinium)”. The Company was incorporated with the objective of manufacturing and supplying various pharma-related chemicals, bulk drugs, pharma intermediates etc.

    Accordingly, the Company is dealing specifically and mainly in manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs).

    The Company has its manufacturing plant at Plot No. 37, 38, 39, 29, 30, 01 GIDC Sojitra, Dist. Anand – 387240, Gujarat, India since inception, spread across 6204.53 sq. Mtrs. of land and its corporate office at Suite 205, Sigma Prime, 2nd Floor, Nr. Sardar Patel Statue, Vallabh Vidhyanagar, Dist. Anand – 388120, Gujarat, India. The Company was formed with a vision to be a globally integrated and admired Pharmaceutical & Healthcare Company

    Infinium Pharmachem IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Lakh)
    30-Sep-22 31-Mar-22 Mar-21 31-Mar-20
    Total Assets 7075.71 5899.95 3418.27 2244.60
    *Total Revenue 7985.39 10005.25 7115.37 3941.64
    Total Expense 7217.13 9142.02 6738.47 3817.76
    Profit After Tax 600.14 668.57 272.99 86.78

    Earnings per Equity Share (in Lakh)

    30-Sep-22 31-Mar-22 Mar-21 31-Mar-20
    Basic & Diluted 10.84 60.07 26.80 9.19

    Further, their PAT for the period ended on Sep 30, 2022, March 31, 2022, March 31, 2021, and March 31, 2020, were Rs. 600.14 Lakh, Rs. 668.57 Lakh, Rs. 272.99 Lakh and Rs. 86.78 Lakh respectively.

    Infinium Pharmachem IPO – Promoters

    The Promoter of this company is:


    List of Related Parties (Key Managerial Personnel)

    • Sanjay Kumar Viththalbhai Patel, Chairman and Managing Director
    • Pravin Bhadabhai Madhani, Executive Director
    • Mitesh Lavjibhai Chikhaliya, Executive Director
    • Keyur Jagdishchandra Shah, Independent Director
    • Tarun Ratilal Dobariya, Independent Director
    • Vaishakhi Ambrishbhai Shukla, Independent Director

    Infinium Pharmachem IPO – Promoters Holding

    • Pre-Issue Share Holding – 100%
    • Post-Issue Share Holding – %

    Infinium Pharmachem IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to 18,75,000 Equity Shares aggregating up to Rs.2,526 Lakh
    of which:
    Issue Reserved for the Market Makers Up to 94,000 Equity Shares aggregating up to Rs.126.90
    Net Issue to the Public Up to 17,40,000 Equity Shares aggregating up to Rs.2,349.00
    Of which:
    Retail Investors Portion Not less than 8,70,000 Equity Shares
    Other than Retail Individual Investors Not more than 8,70,000 Equity Shares
     Equity Shares outstanding prior to the Issue 50,83,060 Equity Shares
     Equity Shares outstanding after the Issue 69,58,060 Equity Shares

    Infinium Pharmachem IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. Marketing and Branding Expenses (including Registration in Reach – Europe, and other marketing expenses);
    2. Repayment of some Existing Loans;
    3. Expansion of Existing Units;
    4. To Meet Incremental Working Capital Requirements;
    5. General Corporate Purpose;
    6. To meet Public Issue Expenses

    Infinium Pharmachem IPO – Business Strategy

    • CRAMS model / Product Development Strategy
    • Focus & investment in Research & Development
    • Expansion in domestic & overseas markets (Geographic Diversification)
    • Wider & Broad Customer base (Industrial Diversification)
    • Customization as a Strategic advantage tool

    Infinium Pharmachem IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Expertise of the Company in Research and Development (R&D) (200+ Iodine Derivatives Researched & Developed);
    • Strong growth in emerging market business;
    • Expanding reach to over 15+ countries across the globe while significantly increasing customer base in India too.
    • Focus on Strategy;
    • Dependable suppliers: The Company has a good quantity of competent raw material suppliers, which allows it to bypass many supply chain bottlenecks.

    The relevant quantitative factors are:

    Basic & Diluted EPS RONW (%) NAV (Rs.)
    31-Mar-22 54.13 43.85 123.45
    31-Mar-21 26.75 38.59
    Mar-20 10.01 23.59

    Infinium Pharmachem IPO: Competitive Peers

    Face Value (Rs.) P/E EPS  (Rs.) Return on Net Worth (%) Total NAV (Rs.)
    Infinium Pharmachem Limited 10 12.47 10.83 43.85 123.45
    Listed Peers
    Samrat Pharmachem Limited 10 12.99 55.62 36.70 151.54

    Infinium Pharmachem IPO Lead Managers

    Lead Managers
    SEBI Registration Number: INM000012102
    Merchant Banking Division Address: Flat No18 Floor 2 North Wing Madhaveshwar
    Coop Hsg Society Ltd Madhav Nagar, 11/12 S V Road Andheri W Mumbai Mumbai City –
    400058 (Maharashtra).
    Telephone Number: +91-22-26254568-69
    Email Id: merchantbanking@swastika.co.in
    Investors Grievance Id: investorgreivance@swastika.co.in
    Website: www.swastika.co.in
    Contact Person: Mr Mohit R. Goyal
    CIN: L65910MH1992PLC067052

    Infinium Pharmachem IPO Registrar to offer

    Registrar to the Offer
    SEBI Registration Number: INR000001385
    Address: Office No. S6 – 2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali
    Caves Road, Andheri – [East], Mumbai – 400093, Maharashtra, India.
    Tel. Number: +91 22 6263 8200
    Fax- +91 22 6263 8299
    Email Id: ipo@bigshareonline.com
    Investors Grievance Id: investor@bigshareonline.com
    Website: www.bigshareonline.com
    Contact Person: Mr Swapnil Kate

    Infinium Pharmachem IPO – Other Details

    • Statutory Auditor – M/s Ashok Rajpara & Co., Chartered Accountants
    • Legal Counsel to the Company – OMS LAW HOUSE
    • Bankers to the Company –  BANK OF BARODA and STATE BANK OF INDIA

    Infinium Pharmachem IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Infinium Pharmachem IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Infinium Pharmachem Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Infinium Pharmachem IPO Review FAQs

      Check out various FAQs related to Infinium Pharmachem IPO:

      What is the Issue Size of Infinium Pharmachem IPO?

      The Company is making an initial public offer of 1,875,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      What is the Price band of Infinium Pharmachem IPO?

      The price band for this particular IPO ranges between Rs 135. As far as the face value of the share is of concern, it is Rs. 10 per share.

      What is the Infinium Pharmachem IPO Open Date?

      The opening and closing dates for this IPO have been updated. The IPO is set to open on Mar 31, 2023, while the closing date is set for Apr 5, 2023.

      What is the Infinium Pharmachem IPO Allotment Date?

      They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on Apr 11, 2023, refund initiation is on Apr 12, 2023, credit of shares is on Apr 13, 2023, and share listing date is on Apr 17, 2023.

      What is the Infinium Pharmachem IPO Listing Date?

      Shares of this company shall be listed in the exchanges on Apr 17, 2023. The date, when the listing would be done, is stagnant on Apr 17, 2023.

      Who is the Registrar of Infinium Pharmachem IPO?

      One of the reputed registrars is managing the issue of this IPO, i.e. Bigshare Services Pvt Ltd. Their website will help you regarding the further information you are on the lookout for.

      Who is the Promoter of Infinium Pharmachem IPO?

      Here are the promoters of this IPO – MR. SANJAY KUMAR VITHTHALBHAI PATEL, MR. PRAVIN BHADABHAI MADHANI AND MR. MITESH LAVJIBHAI CHIKHALIYA. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      What is the GMP of Infinium Pharmachem IPO?

      They have obtained the GMP of this IPO and it is Rs NA. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.

      Is Infinium Pharmachem IPO good for Investment?

      They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      What is the PAT of Infinium Pharmachem Company?

      They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2022 in Lakh is 668.57, 2021 is 272.99, and 2020 is 86.78. PAT from Sep 2022 is 600.14.

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO